British Columbia

B.C. ramps up screening for faster-spreading coronavirus 'variants of concern'

There's a race between COVID-19 and the rollout of vaccine as researchers and health officials in B.C. warn of two faster spreading variants.

Stalled immunization rollout means we're in a 'race between the vaccine and the virus,' SFU professor says

A poster of Dr. Bonnie Henry, B.C.'s provincial health officer, is pictured at a COVID-19 testing centre in Burnaby. The province is sequencing about 15 per cent of samples that test positive for COVID-19 to understand if public health officials are missing anything, such as transmission of new variants. (Ben Nelms/CBC)

There's a race between COVID-19 and the rollout of vaccines as researchers and health officials in B.C. warn of two faster-spreading variants of the coronavirus that causes the disease.

The number of variant cases may start low, but increased transmission could only be a few weeks away, just as delivery of the Pfizer-BioNTech vaccine is delayed, said Caroline Colijn, the Canada 150 Research Chair in Mathematics for Infection, Evolution and Public Health at Simon Fraser University in Burnaby, B.C.

Colijn's lab released modelling data this week showing public health rules in several provinces, including B.C., would not be sufficient to prevent exponential growth in cases starting around March if a coronavirus variant with a 40 per cent higher transmission rate became established.

"By 'established,' I mean some cluster doesn't get stopped and takes off and we don't notice or we don't act and we are unable to stop those chains of transmission, and so they take off the way the current COVID has,'' she said.

Colijn added she would expect public health officials to enact further restrictions before such exponential growth in variant cases.

Variants from South Africa, U.K. detected 

Provincial Health Officer Dr. Bonnie Henry told a news briefing this week that B.C. has detected three cases of a variant found in South Africa and none were linked to each other or to travel, pointing to community spread.

By completing whole genome sequencing, the B.C. Centre for Disease Control (BCCDC) has also recorded six travel-related cases of the variant first found in the United Kingdom, which appears significantly more transmissible than earlier strains of the coronavirus.

A COVID-19 vaccination site in Vancouver. The province reported 4,260 active cases of COVID-19 on Tuesday. There have been more than 65,000 confirmed cases in B.C. since the pandemic began. (Ben Nelms/CBC)

B.C. is sequencing about 15 per cent of samples that test positive for COVID-19 in the province, said Natalie Prystajecky, head of the environmental microbiology program at the BCCDC's public health lab.

Sequencing is more labour intensive than diagnostic testing, she said, so it can take up to two weeks to produce data from a given sample.

B.C. has sequenced about 11,000 positive samples since last February and generated quality data from about 9,500 of them, she said.

The average rate of sequencing across Canada is between five and 10 per cent, said Prystajecky, a member of the Canadian COVID-19 Genomics Network that received funding last spring to sequence 150,000 samples.

Consider a 'Pacific bubble'

In addition to targeting samples from travellers and youth, she said, B.C. is prioritizing more general, "background'' sampling to understand if public health officials are missing anything, such as transmission of new variants.

"We're ramping up,'' she said. "We did 750 genomes last week and we're aiming to continue to increase the amount of sequencing we're doing.''

Prystajecky said her lab is also planning to do a "point prevalence study'' to screen a high number of samples at a given point in time.

B.C. is taking a smart approach to sequencing by targeting travel-related cases, said Colijn, but at the rate sequencing data becomes available, "there could be 10 or 50 or 100 cases of whatever we detect at the time.''

Colijn believes B.C. should consider Atlantic Canada's approach and create a "Pacific bubble" that would require travellers from other provinces to self-isolate for 14 days upon arrival in B.C.

To date, 122,359 doses of a COVID-19 vaccine have been administered in B.C., 4,105 of which are second doses. (Grant Hindsley/AFP/Getty Images)

Data from Pfizer and Moderna — the pharmaceutical companies behind the two COVID-19 vaccines approved in Canada — show their products still protect people against the U.K. and South African variants, said Fiona Brinkman, a professor in the molecular biology and biochemistry department at SFU.

"What this means is people really need to hunker down until this vaccine gets out into the population further,'' she said in an interview this week. "We really are in a race between the vaccine and the virus right now.''

Basic measures including physical distancing and avoiding non-essential travel are still effective in preventing new variants from spreading, she said.

B.C. reported 4,260 active cases of COVID-19 on Tuesday out of more than 65,000 confirmed cases since the pandemic began.


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Become a CBC Member

Join the conversation  Create account

Already have an account?